Vishnu Kant

Publications

Citations

H-Index

2018

Active since

Affiliations

National Institute of Pharmaceutical Education and Research(Current)

Rajendra Memorial Research Institute of Medical Sciences

Vishnu Kant is an author at National Institute of Pharmaceutical Education and Research specializing in drug discovery, medicinal chemistry, and natural sciences.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryBiochemistryChemical BiologyDrug DevelopmentMolecular BiologyBiocatalysis

Publications per year

2018–2022

Publications

In-silico screening and validation of high-affinity tetra-peptide inhibitor of <i>Leishmania donovani</i> O-acetyl serine sulfhydrylase (OASS)

Vishnu Kant, Saravanan Vijayakumar, Ganesh Chandra Sahoo et al. · Journal of Biomolecular Structure and Dynamics · 2018 · 23 citations

High-affinity Tetra-peptide Inhibitor, Leishmania Donovani Oass, Antiparasitic Agent +19

In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferase

Vishnu Kant, Pawan Kumar, Ravi Ranjan et al. · Parasitology Research · 2022 · 19 citations · Full text

Medicinal Chemistry, Silico Screening, Bioorganic Chemistry +12

LeishInDB: A web-accessible resource for small molecule inhibitors against Leishmania sp

Saravanan Vijayakumar, Vishnu Kant, Pradeep Das · Acta Tropica · 2018 · 15 citations

Small Molecule Inhibitors, Medicinal Chemistry, Web-accessible Resource +13

Rows per page

1–3 of 3